{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03194893",
            "orgStudyIdInfo": {
                "id": "BO39694"
            },
            "secondaryIdInfos": [
                {
                    "id": "2017-000207-24",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Hoffmann-La Roche",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer",
            "officialTitle": "A Multicenter, International, Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-rollover-study-of-alectinib-in-patients-with-anaplastic-lymphoma-kinase-alk-positive-or-rearranged-during-transfection-ret-positive-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-07-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-06-20",
            "studyFirstSubmitQcDate": "2017-06-20",
            "studyFirstPostDateStruct": {
                "date": "2017-06-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Hoffmann-La Roche",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to provide continued treatment with alectinib or crizotinib as applicable to participants with ALK- or RET positive cancer who were previously enrolled in any Roche-sponsored alectinib study and who are deriving continued clinical benefit from alectinib or crizotinib in the parent trial at the time of parent trial closure."
        },
        "conditionsModule": {
            "conditions": [
                "Neoplasms"
            ],
            "keywords": [
                "Non-small cell lung cancer (NSCLC)",
                "Anaplastic lymphoma kinase (ALK)",
                "Rearranged during transfection (RET)",
                "Alectinib",
                "Crizotinib"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Alectinib",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive alectinib at the same dose and schedule and according to the same administration guidelines as they received at the time of discontinuation from the parent trial.",
                    "interventionNames": [
                        "Drug: Alectinib"
                    ]
                },
                {
                    "label": "Crizotinib",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive crizotinib at the same dose and schedule and according to the same administration guidelines as they received at the time of discontinuation from the parent trial.",
                    "interventionNames": [
                        "Drug: Crizotinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Alectinib",
                    "description": "Alectinib capsules 600 mg twice a day (BID) orally until no further clinical benefit is to be expected, unacceptable toxicity, availability of commercial supply, withdrawal of consent, or death, whichever occurs first.",
                    "armGroupLabels": [
                        "Alectinib"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Crizotinib",
                    "description": "Crizotinib capsules 250 mg BID orally until no further clinical benefit is to be expected, unacceptable toxicity, availability of commercial supply, withdrawal of consent, or death, whichever occurs first.",
                    "armGroupLabels": [
                        "Crizotinib"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Patients with Serious Adverse Events (SAEs), Non-serious Adverse Events (non-SAEs) and Adverse Events of Special Interest",
                    "description": "An AE is considered any unfavorable and unintended sign, symptom, or disease associated with use of study drug, whether or not considered related to study drug. Preexisting conditions that worsened during study and laboratory or clinical tests that resulted in a change in treatment or discontinuation from study drug is reported as adverse events. A SAE is any experience that suggests a significant hazard, contraindication, side effect that: results in death, is life-threatening, required in-patient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect or is medically significant. Adverse events of special interest are cases of potential drug-induced liver injury that include an elevated alanine transaminase (ALT) or aspartate transaminase (AST) in combination with either an elevated bilirubin or clinical jaundice and suspected transmission of an infectious agent by study drug.",
                    "timeFrame": "From first dose of study treatment and until the safety follow-up visit (4 weeks after the last dose of study treatment)"
                },
                {
                    "measure": "Number of Patients With Clinically Significant Laboratory Values as per Protocol for Selected Safety Laboratory Parameters",
                    "description": "Selected safety laboratory parameters include alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin, alkaline phosphatase (ALP), and blood creatine phosphokinase (CPK). Any treatment-emergent abnormal laboratory result accompanied by clinical symptoms or leading to a change in study medication or requiring a change in concomitant therapy is considered clinically significant.",
                    "timeFrame": "From first dose of study treatment and until the safety follow-up visit (4 weeks after the last dose of study treatment)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number and Causes of Death Occurring on Study",
                    "description": "Once a patient has permanently discontinued study drug and completed the safety follow-up visit, no further survival data will be collected.",
                    "timeFrame": "From first dose of study treatment and until the safety follow-up visit (4 weeks after the last dose of study treatment)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants enrolled in a Roche-sponsored alectinib trial who are experiencing a clinical benefit from alectinib or crizotinib treatment at the time of discontinuation from the parent trial and for whom a switch to commercial supply is not feasible\n* Collected study termination data, including efficacy and safety data, as required by the parent study on the electronic Case Report Form (eCRF)\n* For women who are not postmenopausal (\u2265 12 months of non-therapy-induced amenorrhea) or surgically sterile (absence of ovaries and/or uterus): agreement to remain abstinent or use single or combined contraceptive methods that result in a failure rate of \\< 1% per year during the treatment period and for at least 3 months after the last dose of study drug\n* For men: agreement to remain abstinent or use a contraceptive method that results in a failure rate of \\< 1% per year during the treatment period and for at least 3 months after the last dose of study drug.\n\nExclusion Criteria:\n\n* Evidence of lack of clinical benefit in parent trial during the screening phase of this rollover study\n* Permanent discontinuation of alectinib or crizotinib for any reason during the parent study or before first dose of study drug in the rollover study\n* Evidence of an adverse event for which the parent protocol stipulates permanent discontinuation\n* Pregnant or breastfeeding women\n* Ongoing serious adverse event that has not resolved to baseline level or Grade \u22641 prior to first dose of study treatment in the rollover study\n* Treatment interruption for more than 21 days due to an adverse event since the last administration of alectinib or crizotinib in the parent trial. Any ongoing adverse events that require temporary treatment interruption must be resolved to baseline grade or assessed as stable and not requiring further treatment interruption by the investigator\n* Administration of strong/potent cytochrome P450 (CYP) 3A inhibitors or inducers within 14 days prior to the first dose of treatment on this study and while on treatment with crizotinib\n* Any psychological, familial, sociological, or geographical condition potentially hampering compliance with the study protocol requirements and/or follow-up procedures; these conditions should be discussed with the participant before trial entry",
            "healthyVolunteers": false,
            "sex": "ALL",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Reference Study ID Number: BO39694 www.roche.com/about_roche/roche_worldwide.htm",
                    "role": "CONTACT",
                    "phone": "+1 888-662-6728",
                    "email": "global-roche-genentech-trials@gene.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trials",
                    "affiliation": "Hoffmann-La Roche",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Chao Family Comprehensive Cancer Center; UC Irvine Medical Center",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "Miami Cancer Institute of Baptist Health, Inc.",
                    "status": "COMPLETED",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33176",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Massachusetts General Hospital Cancer Center",
                    "status": "COMPLETED",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Guangdong General Hospital",
                    "status": "WITHDRAWN",
                    "city": "Guangzhou",
                    "zip": "510080",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "The First Affiliated Hospital of Guangzhou Medical University",
                    "status": "WITHDRAWN",
                    "city": "Guangzhou",
                    "zip": "510120",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "Shanghai Pulmonary Hospital",
                    "status": "WITHDRAWN",
                    "city": "Shanghai",
                    "zip": "200433",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Zhejiang Cancer Hospital",
                    "status": "WITHDRAWN",
                    "city": "Zhejiang",
                    "zip": "310022",
                    "country": "China"
                },
                {
                    "facility": "Centre Francois Baclesse",
                    "status": "COMPLETED",
                    "city": "Caen",
                    "zip": "14076",
                    "country": "France",
                    "geoPoint": {
                        "lat": 49.18585,
                        "lon": -0.35912
                    }
                },
                {
                    "facility": "Centre Georges Fran\u00e7ois Leclerc; Service Pharmacie, Bp 77980",
                    "status": "COMPLETED",
                    "city": "Dijon",
                    "zip": "21000",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.31667,
                        "lon": 5.01667
                    }
                },
                {
                    "facility": "Centre Oscar Lambret",
                    "status": "COMPLETED",
                    "city": "Lille",
                    "zip": "59020",
                    "country": "France",
                    "geoPoint": {
                        "lat": 50.63297,
                        "lon": 3.05858
                    }
                },
                {
                    "facility": "Centre Leon Berard",
                    "status": "COMPLETED",
                    "city": "Lyon",
                    "zip": "69008",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "Groupe Hospitalier Sud - H\u00f4pital Haut L\u00e9v\u00eaque",
                    "status": "COMPLETED",
                    "city": "Pessac",
                    "zip": "33600",
                    "country": "France",
                    "geoPoint": {
                        "lat": 44.81011,
                        "lon": -0.64129
                    }
                },
                {
                    "facility": "Hopital Pontchaillou - CHU de Rennes",
                    "status": "COMPLETED",
                    "city": "Rennes",
                    "zip": "35033",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.11198,
                        "lon": -1.67429
                    }
                },
                {
                    "facility": "CHU de Toulouse - H\u00f4pital Larrey; Service de pneumologie et oncologie pneumologique",
                    "status": "COMPLETED",
                    "city": "Toulouse cedex 9",
                    "zip": "31100",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.60426,
                        "lon": 1.44367
                    }
                },
                {
                    "facility": "Hopital Robert Schuman; Pneumologie",
                    "status": "COMPLETED",
                    "city": "Vantoux",
                    "zip": "57070",
                    "country": "France"
                },
                {
                    "facility": "Queen Mary Hospital; Dept. of Clinical Oncology",
                    "status": "COMPLETED",
                    "city": "Hong Kong",
                    "country": "Hong Kong",
                    "geoPoint": {
                        "lat": 22.27832,
                        "lon": 114.17469
                    }
                },
                {
                    "facility": "Queen Elizabeth Hospital Department of Clinical Oncology",
                    "status": "COMPLETED",
                    "city": "Kowloon",
                    "country": "Hong Kong",
                    "geoPoint": {
                        "lat": 22.31667,
                        "lon": 114.18333
                    }
                },
                {
                    "facility": "Irccs Centro Di Riferimento Oncologico (CRO); Dipartimento Di Oncologia Medica",
                    "status": "COMPLETED",
                    "city": "Aviano",
                    "state": "Friuli-Venezia Giulia",
                    "zip": "33081",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 46.07056,
                        "lon": 12.59472
                    }
                },
                {
                    "facility": "Azienda Ospedaliera San Camillo Forlanini - Unit\u00e0 Operativa Complessa di Pneumologia Oncologica 1",
                    "status": "COMPLETED",
                    "city": "Roma",
                    "state": "Lazio",
                    "zip": "00151",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Irccs Istituto Europeo di Oncologia (IEO); Divisione di Oncologia",
                    "status": "WITHDRAWN",
                    "city": "Milano",
                    "state": "Lombardia",
                    "zip": "20141",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Azienda Ospedaliero-Universitaria Careggi;S.C. Oncologia Medica 1",
                    "status": "COMPLETED",
                    "city": "Firenze",
                    "state": "Toscana",
                    "zip": "50139",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 43.77925,
                        "lon": 11.24626
                    }
                },
                {
                    "facility": "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica",
                    "status": "COMPLETED",
                    "city": "Perugia",
                    "state": "Umbria",
                    "zip": "06156",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 43.1122,
                        "lon": 12.38878
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "COMPLETED",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "COMPLETED",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Uniwersyteckie Centrum Kliniczne; Klinika Onkologii i Radioterapii",
                    "status": "COMPLETED",
                    "city": "Gdansk",
                    "zip": "80-214",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 54.35205,
                        "lon": 18.64637
                    }
                },
                {
                    "facility": "FSBSI \"Russian Oncological Scientific Center n.a. N.N. Blokhin\"",
                    "status": "COMPLETED",
                    "city": "Moscow",
                    "state": "Moskovskaja Oblast",
                    "zip": "115478",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "University ?linic of headaches",
                    "status": "COMPLETED",
                    "city": "Moscow",
                    "state": "Moskovskaja Oblast",
                    "zip": "121467",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "City Clinical Oncology Hospital",
                    "status": "COMPLETED",
                    "city": "Moscow",
                    "state": "Moskovskaja Oblast",
                    "zip": "143423",
                    "country": "Russian Federation",
                    "geoPoint": {
                        "lat": 55.75222,
                        "lon": 37.61556
                    }
                },
                {
                    "facility": "Hospital del Mar; Servicio de Oncologia",
                    "status": "COMPLETED",
                    "city": "Barcelona",
                    "zip": "08003",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica",
                    "status": "COMPLETED",
                    "city": "Barcelona",
                    "zip": "08028",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitario La Paz; Servicio de Oncologia",
                    "status": "COMPLETED",
                    "city": "Madrid",
                    "zip": "28046",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Adana Ac?badem Hospital Oncology Department",
                    "status": "COMPLETED",
                    "city": "Adana",
                    "zip": "01130",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 37.00167,
                        "lon": 35.32889
                    }
                },
                {
                    "facility": "Istanbul Uni Capa Medical Faculty; Inst. of Oncology",
                    "status": "COMPLETED",
                    "city": "Istanbul",
                    "zip": "34093",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Ege University Medical Faculty; Chest Diseases",
                    "status": "RECRUITING",
                    "city": "Izmir",
                    "zip": "35040",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 38.41273,
                        "lon": 27.13838
                    }
                },
                {
                    "facility": "Hacettepe Uni Medical Faculty Hospital; Oncology Dept",
                    "status": "RECRUITING",
                    "city": "Sihhiye/Ankara",
                    "zip": "06230",
                    "country": "Turkey"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077547",
                    "term": "Crizotinib"
                },
                {
                    "id": "C000582670",
                    "term": "Alectinib"
                }
            ],
            "ancestors": [
                {
                    "id": "D000092004",
                    "term": "Tyrosine Kinase Inhibitors"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1825",
                    "name": "Crizotinib",
                    "asFound": "Supplemental",
                    "relevance": "HIGH"
                },
                {
                    "id": "M145666",
                    "name": "Alectinib",
                    "asFound": "Indwelling",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2889",
                    "name": "Tyrosine Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T22",
                    "name": "Tyrosine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}